Glutathione, the active ingredient in this formulation, is a potent antioxidant that aids in reducing oxidative stress and inflammation
Sulbactam, Durlobactam (Xacduro) was officially approved by the FDA on May 23, 2023, for the treatment of pneumonia caused by certain difficult-to-treat bacteria
Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method
Reduced cortical -aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy
DSIP is available in 2mg, 5mg, and 10mg peptide vials
6c, d), which together with increased ROS (Fig